Biolidics, LC-Bio team up to develop cancer diagnostic solutions

Biolidics will be LC-Bio's exclusive partner in China for five years.

Biolidics has entered into a collaboration agreement with LC-Bio Technologies, Hangzhou (LC-Bio) to develop cancer diagnostic solutions for a duration of five years, according to an announcement.

Biolidics will be LC-Bio's exclusive partner in China for the development of the solutions at LC-Bio's medical laboratory located in Hangzhou. It will be using Biolidics’ proprietary circulating tumour cell technology .

However, the firm may partner with entities other than LC-Bio on the project to develop solutions outside of Zhejiang.

Biolidics will provide all necessary materials and relevant consumables and will be responsible for the market promotion as well as application of the cancer diagnostic solutions once it passes the relevant clinical validation test whilst LC-Bio will be responsible for the issuance of the test result reports in its name and will provide the qualified medical laboratories and space required for the solution.

Both have also agreed to provide any other additional manpower and necessary support for the development and clinical application of the cancer-diagnostic solution.

Biolidics’ board believes that the project is complementary to its core business in the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection, and treatment monitoring.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia